| Dr John David Mccain, MD | |
|
459 Corporate Dr, Houma, LA 70360-2462 | |
| (985) 868-4333 | |
| (985) 868-4390 |
| Full Name | Dr John David Mccain |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 35 Years |
| Location | 459 Corporate Dr, Houma, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316026560 | NPI | - | NPPES |
| 1900788 | Medicaid | LA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franklin Foundation Hospital | Franklin, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Teche Emergency Group Llc | 0547456295 | 7 |
News Archive
People have long taken for granted that glasses and contact lenses improve vision for nearsightedness, but the genetic factors behind the common condition have remained blurry. Now researchers at Duke Medicine are closer to clearing this up.
In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide.
As Lecheler celebrates the New Year, she is sharing her breast cancer survival techniques with business executives and others who are looking for a resolution they can keep - having a healthier and happier 2011. Lecheler offers up her integrated healing tips in her new book The Spirit to Heal.
Cancer information charity CancerBACUP is calling for action following today's Healthcare Commission report, which highlights particular concerns about patient information and the lack of patient involvement in their treatment and care.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
› Verified 1 days ago
| Entity Name | Teche Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356658884 PECOS PAC ID: 0547456295 Enrollment ID: O20101122000141 |
News Archive
People have long taken for granted that glasses and contact lenses improve vision for nearsightedness, but the genetic factors behind the common condition have remained blurry. Now researchers at Duke Medicine are closer to clearing this up.
In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide.
As Lecheler celebrates the New Year, she is sharing her breast cancer survival techniques with business executives and others who are looking for a resolution they can keep - having a healthier and happier 2011. Lecheler offers up her integrated healing tips in her new book The Spirit to Heal.
Cancer information charity CancerBACUP is calling for action following today's Healthcare Commission report, which highlights particular concerns about patient information and the lack of patient involvement in their treatment and care.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John David Mccain, MD 459 Corporate Dr, Houma, LA 70360-2462 Ph: (985) 868-4333 | Dr John David Mccain, MD 459 Corporate Dr, Houma, LA 70360-2462 Ph: (985) 868-4333 |
News Archive
People have long taken for granted that glasses and contact lenses improve vision for nearsightedness, but the genetic factors behind the common condition have remained blurry. Now researchers at Duke Medicine are closer to clearing this up.
In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide.
As Lecheler celebrates the New Year, she is sharing her breast cancer survival techniques with business executives and others who are looking for a resolution they can keep - having a healthier and happier 2011. Lecheler offers up her integrated healing tips in her new book The Spirit to Heal.
Cancer information charity CancerBACUP is calling for action following today's Healthcare Commission report, which highlights particular concerns about patient information and the lack of patient involvement in their treatment and care.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
› Verified 1 days ago
Mrs. Tanya Goff Howard, OT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 240 Ravensaide Dr, Houma, LA 70360 Phone: 985-713-9040 | |
Hector A Linares-magana, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8166 Main St, Houma, LA 70360 Phone: 985-873-4141 Fax: 985-851-4307 | |
Mary Mathai, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1978 Industrial Blvd, Houma, LA 70363 Phone: 985-873-2200 | |
Angelo Ocampo Limcangco, BS Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 107 S Hollywood Rd, Houma, LA 70360 Phone: 985-876-3250 | |
Catherine Calandro Nelson, PT, WCC, CLT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 7843 Park Ave, Houma, LA 70364 Phone: 985-876-5322 |